Suppression of Induction of Experimental Immune Mediated Blepharoconjunctivitis by Tolerogenic Conjugates of the Antigen and Monomethoxypolyethylene Glycol

Overview

Journal Br J Ophthalmol

Specialty Ophthalmology

Date 1999 Jul 22

PMID 10413705

Authors

A Fukushima

K Nishino

H Yoshida

M Takata

H Ueno

Affiliations

Soon will be listed here.

Abstract

Aim: Covalent conjugates consisting of diverse antigens coupled to optimal numbers of monomethoxypolyethylene glycol (mPEG) molecules have been shown to suppress antigen specific antibody formation. In this study, the possibility was examined that the same conjugates might prevent experimental immune mediated blepharoconjunctivitis (EC, formerly EAC) which had been shown to be caused by CD4(+) T cells-that is, to cell mediated immunity.

Methods: 6-8 week old male Lewis rats were used. The test groups of rats received two intravenous injections, each of 300 microg, of a conjugate of ovalbumin mPEG (OVA(mPEG)(11)) in phosphate buffered saline (PBS), 14 and 28 days before the single immunisation with OVA in complete Freund's adjuvant. The rats were challenged 3 weeks later by eye drops containing OVA; 24 hours later they were sacrificed, and their eyes, blood, and lymph nodes were harvested for histological examination and determination of anti-OVA antibody titres and levels of cellular immunity. Two control groups received PBS or OVA in PBS before immunisation. Furthermore, the possibility that OVA(mPEG)(11) may have induced OVA specific suppressor cells was tested by establishing the effects of the co-transfer of splenocytes from OVA(mPEG)(11) treated rats with OVA primed lymph node cells on the manifestations of EC.

Results: Either PBS or OVA pretreated rats, which had not received OVA(mPEG)(11), developed high levels of antibodies and cell mediated immune responses to OVA, and application of eye drops led to blepharoconjunctivitis with massive cellular infiltration. In contrast, pretreatment with OVA(mPEG)(11) prevented cellular infiltration into the lids and conjunctivas, as well as the formation of detectable humoral and cellular immunity against OVA. Co-transfer of splenocytes from OVA(mPEG)(11) treated rats with OVA primed lymph node cells suppressed the cellular infiltration on application of OVA on the conjunctiva.

Conclusions: These data indicate that intravenous injection of OVA(mPEG)(11) conjugates suppressed both humoral and cellular immunity by the effects of antigen specific suppressor cells, thus leading to the inhibition of development of EC.

References

Mota I . On the site of rat reagin formation. Immunology. 1966; 11(2):137-40. PMC: 1423767. View

Yoshida H, Yoshida O, Iwamoto H, Nishino K, Hashida M, Fukushima A . Analysis of effects of stimulation in vitro of ovalbumin primed lymph node cells on adoptive transfer of experimental immune mediated blepharoconjunctivitis in Lewis rats. Br J Ophthalmol. 1999; 82(10):1189-94. PMC: 1722375. DOI: 10.1136/bjo.82.10.1189. View

Walters C, Moorhead J, Claman H . Immunity tolerance to a hapten (NIP) coupled to an isologous carrier (mouse gamma globulin). J Exp Med. 1972; 136(3):546-55. PMC: 2139250. DOI: 10.1084/jem.136.3.546. View

Chiller J, Romball C, Weigle W . Induction of immunological tolerance in neonatal and adult rabbits. Differences in the cellular events. Cell Immunol. 1973; 8(1):28-39. DOI: 10.1016/0008-8749(73)90090-7. View

Lee W, Sehon A . Abrogation of reaginic antibodies with modified allergens. Nature. 1977; 267(5612):618-9. DOI: 10.1038/267618a0. View

RAUCH H . Modulation of adoptive cell transfers in experimental allergic encephalomyelitis by antigen treatment of donors. Cell Immunol. 1981; 60(1):220-7. DOI: 10.1016/0008-8749(81)90262-8. View

Jackson C, Charlton J, Kuzminski K, Lang G, Sehon A . Synthesis, isolation, and characterization of conjugates of ovalbumin with monomethoxypolyethylene glycol using cyanuric chloride as the coupling agent. Anal Biochem. 1987; 165(1):114-27. DOI: 10.1016/0003-2697(87)90208-9. View

Nussenblatt R, Caspi R, Mahdi R, Chan C, Roberge F, Lider O . Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen. J Immunol. 1990; 144(5):1689-95. View

Cobbold S, Qin S, Leong L, Martin G, Waldmann H . Reprogramming the immune system for peripheral tolerance with CD4 and CD8 monoclonal antibodies. Immunol Rev. 1992; 129:165-201. DOI: 10.1111/j.1600-065x.1992.tb01423.x. View

10.

Weiner H, Mackin G, Matsui M, Orav E, Khoury S, Dawson D . Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science. 1993; 259(5099):1321-4. DOI: 10.1126/science.7680493. View

11.

Bitoh S, Takata M, Maiti P, Sehon A . Antigen-specific suppressor factors of noncytotoxic CD8+ suppressor T cells downregulate antibody responses also to unrelated antigens when the latter are presented as covalently linked adducts with the specific antigen. Cell Immunol. 1993; 150(1):168-93. DOI: 10.1006/cimm.1993.1188. View

12.

Saoudi A, Kuhn J, Huygen K, De Kozak Y, Velu T, Goldman M . TH2 activated cells prevent experimental autoimmune uveoretinitis, a TH1-dependent autoimmune disease. Eur J Immunol. 1993; 23(12):3096-103. DOI: 10.1002/eji.1830231208. View

13.

Kuchroo V, Greer J, Kaul D, Ishioka G, Franco A, Sette A . A single TCR antagonist peptide inhibits experimental allergic encephalomyelitis mediated by a diverse T cell repertoire. J Immunol. 1994; 153(7):3326-36. View

14.

Roman E, Harris D, Jurcevic S, Ivanyi J, Moreno C . H-2-associated effects of flanking residues on the recognition of a permissive mycobacterial T-cell epitope. Immunology. 1995; 86(2):183-9. PMC: 1383993. View

15.

Kezuka T, Sakai J, Yokoi H, Takeuchi M, Okada A, Taguchi O . Peptide-mediated suppression of experimental autoimmune uveoretinitis in mice: development of a peptide vaccine. Int Immunol. 1996; 8(8):1229-35. DOI: 10.1093/intimm/8.8.1229. View

16.

Nussenblatt R, Gery I, Weiner H, Ferris F, Shiloach J, Remaley N . Treatment of uveitis by oral administration of retinal antigens: results of a phase I/II randomized masked trial. Am J Ophthalmol. 1997; 123(5):583-92. DOI: 10.1016/s0002-9394(14)71070-0. View

17.

Fukushima A, Yoshida H, Iwamoto H, Yoshida O, Ueno H . The role of cellular immunity both in the induction and effector phases of experimental allergic blepharoconjunctivitis (EAC) in rats. Exp Eye Res. 1998; 65(5):631-7. DOI: 10.1006/exer.1997.0362. View

18.

Fukushima A, Nishino K, Yoshida O, Ueno H . Characterization of the immunopathogenic responses to ovalbumin peptide 323-339 in experimental immune-mediated blepharoconjunctivitis in Lewis rats. Curr Eye Res. 1998; 17(8):763-9. View

19.

Gery I, Waksman B . Role of the thymus in tolerance. V. Suppressive effect of treatment with nonaggregated and aggregated bovine gamma-globulin on specific immune responses in normal adult rats. J Immunol. 1967; 98(3):446-60. View